These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27645371)

  • 21. Parents' and Adolescents' Preferences for Intensified or Reduced Treatment in Randomized Lymphoblastic Leukemia Trials.
    Tulstrup M; Larsen HB; Castor A; Rossel P; Grell K; Heyman M; Abrahamsson J; Söderhäll S; Åsberg A; Jonsson OG; Vettenranta K; Frandsen TL; Albertsen BK; Schmiegelow K;
    Pediatr Blood Cancer; 2016 May; 63(5):865-71. PubMed ID: 26717887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with abandonment of therapy by children diagnosed with solid tumors in Peru.
    Vasquez L; Diaz R; Chavez S; Tarrillo F; Maza I; Hernandez E; Oscanoa M; García J; Geronimo J; Rossell N
    Pediatr Blood Cancer; 2018 Jun; 65(6):e27007. PubMed ID: 29431252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries.
    Metzger ML; Howard SC; Fu LC; Peña A; Stefan R; Hancock ML; Zhang Z; Pui CH; Wilimas J; Ribeiro RC
    Lancet; 2003 Aug; 362(9385):706-8. PubMed ID: 12957095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment refusal and abandonment in children with acute lymphoblastic leukemia.
    Wang YR; Jin RM; Xu JW; Zhou D
    Pediatr Hematol Oncol; 2011 Apr; 28(3):249-50. PubMed ID: 21271779
    [No Abstract]   [Full Text] [Related]  

  • 25. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
    Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial.
    Hunault M; Truchan-Graczyk M; Caillot D; Harousseau JL; Bologna S; Himberlin C; Guyotat D; Berthou C; Casassus P; Baranger L; Béné MC; Ifrah N; Gyan E;
    Haematologica; 2007 Dec; 92(12):1623-30. PubMed ID: 18055985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Impact of Intensified Maintenance Therapy on Children With Advanced Lymphoblastic Lymphoma: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study.
    Sunami S; Sekimizu M; Takimoto T; Mori T; Mitsui T; Fukano R; Saito AM; Watanabe T; Ohshima K; Fujimoto J; Nakazawa A; Kobayashi R; Horibe K; Tsurusawa M
    Pediatr Blood Cancer; 2016 Mar; 63(3):451-7. PubMed ID: 26585702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study.
    Balduzzi A; Valsecchi MG; Uderzo C; De Lorenzo P; Klingebiel T; Peters C; Stary J; Felice MS; Magyarosy E; Conter V; Reiter A; Messina C; Gadner H; Schrappe M
    Lancet; 2005 Aug 20-26; 366(9486):635-42. PubMed ID: 16112299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Childhood acute lymphoblastic leukemia in Nicaragua: long-term results in the context of an international cooperative program.
    Pacheco C; Lucchini G; Valsecchi MG; Malta A; Conter V; Flores A; Biondi A; Tognoni G; Arguello M; Cavalli F; Silvestri D; Lacayo FB; Masera G
    Pediatr Blood Cancer; 2014 May; 61(5):827-32. PubMed ID: 24376241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing childhood leukaemia treatment before and after the introduction of a parental education programme in Indonesia.
    Mostert S; Sitaresmi MN; Gundy CM; Janes V; Sutaryo ; Veerman AJ
    Arch Dis Child; 2010 Jan; 95(1):20-5. PubMed ID: 19679573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
    Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopoietic stem cell transplantation following unsuccessful salvage treatment for relapsed acute lymphoblastic leukemia in children.
    Inagaki J; Fukano R; Noguchi M; Kurauchi K; Tanioka S; Okamura J
    Pediatr Blood Cancer; 2015 Apr; 62(4):674-9. PubMed ID: 25546601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of treatment abandonment for patients with pediatric cancer at Indus Children Cancer Hospital, Karachi, Pakistan.
    Siddiqui DE; Ashraf MS; Iftikhar S; Belgaumi AF
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28960700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Childhood acute lymphoblastic leukemia in Turkey: factors influencing treatment and outcome: a single center experience.
    Hazar V; Karasu GT; Uygun V; Akcan M; Küpesiz A; Yesilipek A
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):e317-22. PubMed ID: 20930649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Socioeconomic status and event free survival in pediatric acute lymphoblastic leukemia: a population-based cohort study.
    Gupta S; Sutradhar R; Guttmann A; Sung L; Pole JD
    Leuk Res; 2014 Dec; 38(12):1407-12. PubMed ID: 25224660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. StatBite: five-year survival rates among children with acute lymphoblastic leukemia.
    J Natl Cancer Inst; 2009 May; 101(10):703. PubMed ID: 19436034
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia.
    Pui CH; Pei D; Sandlund JT; Campana D; Ribeiro RC; Razzouk BI; Rubnitz JE; Howard SC; Hijiya N; Jeha S; Cheng C; Downing JR; Evans WE; Relling MV; Hudson M
    J Clin Oncol; 2005 Nov; 23(31):7936-41. PubMed ID: 16258093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interventions targeting absences increase adherence and reduce abandonment of childhood cancer treatment in El Salvador.
    Salaverria C; Rossell N; Hernandez A; Fuentes Alabi S; Vasquez R; Bonilla M; Lam CG; Ribeiro RC
    Pediatr Blood Cancer; 2015 Sep; 62(9):1609-15. PubMed ID: 25925227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: prognostic factors, treatment and outcome.
    Oskarsson T; Söderhäll S; Arvidson J; Forestier E; Montgomery S; Bottai M; Lausen B; Carlsen N; Hellebostad M; Lähteenmäki P; Saarinen-Pihkala UM; Jónsson ÓG; Heyman M;
    Haematologica; 2016 Jan; 101(1):68-76. PubMed ID: 26494838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.